Yasukata Ohashi Selected Research

Yasukata Ohashi Research Topics

4	Neoplasms (Cancer) 01/2013 - 01/2003
4	Neoplasm Metastasis (Metastasis) 06/2007 - 01/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2010 - 06/2007
2	Lung Neoplasms (Lung Cancer) 01/2013 - 06/2007
2	Exanthema (Rash) 01/2013 - 07/2010
1	Blister (Bulla) 10/2021
1	Multiple Myeloma 09/2020
1	Diarrhea 08/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2009
1	Anorexia 08/2009
1	Lymphatic Metastasis 06/2007
1	Hepatocellular Carcinoma (Hepatoma) 08/2003
1	Liver Neoplasms (Liver Cancer) 08/2003

2	Lenalidomide (CC 5013)FDA Link 10/2021 - 09/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2020 - 01/2013
2	Biological ProductsIBA 01/2013 - 06/2007
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2010 - 08/2009
2	Tyrosine Kinase InhibitorsIBA 07/2010 - 08/2009
2	ErbB Receptors (EGF Receptor)IBA 07/2010 - 08/2009
2	Gefitinib (Iressa)FDA Link 07/2010 - 08/2009
1	ixazomibIBA 09/2020
1	SteroidsIBA 01/2013
1	Chemotactic FactorsIBA 01/2013
1	Chemokine CX3CL1IBA 01/2013
1	ChemokinesIBA 01/2013
1	Pemetrexed (MTA)FDA Link 01/2013
1	LigandsIBA 06/2007
1	TAC 101IBA 08/2003
1	Benzoic Acid (Potassium Benzoate)FDA Link 08/2003
1	Messenger RNA (mRNA)IBA 05/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2003
1	Peptide Hydrolases (Proteases)FDA Link 05/2003
1	Matrix Metalloproteinases (MMPs)IBA 05/2003
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2003
1	N- hydroxy- 5- ethoxymethyloxy- 2- methyl- 4- (4- phenoxybenzoyl)aminopentanamideIBA 05/2003
1	matrigelIBA 01/2003
1	CurcuminIBA 01/2003

3	Therapeutics 09/2020 - 06/2007
2	Oral Administration 08/2003 - 01/2003